{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:18:57Z","timestamp":1784168337485,"version":"3.55.0"},"reference-count":197,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["EM\/DEV\/SG\/1D-1559\/2023\/JJC"],"award-info":[{"award-number":["EM\/DEV\/SG\/1D-1559\/2023\/JJC"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s13346-025-01971-0","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T15:34:12Z","timestamp":1758209652000},"page":"1188-1221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Core-shell nanotherapeutics for diabetic cataract and retinopathy: current state-of-the-art and translational challenges"],"prefix":"10.1007","volume":"16","author":[{"given":"Gitika","family":"Kumari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourabh","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paras","family":"Famta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna K.","family":"Kalahasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geereddy Bhanuprakash","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1171-0668","authenticated-orcid":false,"given":"Dadi A.","family":"Srinivasarao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"1971_CR1","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S2213-8587(23)00119-5","volume":"11","author":"RM Anjana","year":"2023","unstructured":"Anjana RM, Unnikrishnan R, Deepa M, Pradeepa R, Tandon N, Das AK, Joshi S, Bajaj S, Jabbar PK, Das HK, Kumar A, Dhandhania VK, Bhansali A, Rao PV, Desai A, Kalra S, Gupta A, Lakshmy R, Madhu SV, Elangovan N, Chowdhury S, Venkatesan U, Subashini R, Kaur T, Dhaliwal RS, Mohan V, Mohan V, Anjana RM, Unnikrishnan R, Pradeepa R, Deepa M, Sudha V, Nirmal E, Subashini R, Venkatesan U, Nath LM, Lakshmy R, Tandon N, Mahanta J, Madhu SV, Das AK, Pandey A, Dhaliwal RS, Kaur T, Rao PV, Rao MN, Jampa L, Kaki T, Das HK, Borah PK, Kumar A, Sharma S, Bhansali A, Dash K, Shrivas VK, Krishnan A, Desai A, Dias A, Saboo B, Padhiyar JM, Kalra S, Kalra B, Mokta JK, Gulepa R, Dhandhania VK, Adhikari P, Rao S, Jabbar PK, Jayakumari C, Jain SM, Gupta G, Joshi S, Yajnik CS, Joshi PP, Ningombam S, Singh TB, Budnah RO, Basaiawmoit MR, Rosangluaia PC, Lalramenga V, Suokhrie S, Tunyi SK, Tripathy NC, Sahu AJ, Purty M, John A, Gupta BL, Gupta SK, Shrivastava KJ, Tobgay TT, Kaleon T, Reang SK, Das S, Bajaj MK, Mathur S, Modi R, Kakkar S, Chowdhury S, Ghosh. Metabolic non-communicable disease health report of india: the ICMR-INDIAB National cross-sectional study (ICMR-INDIAB-17). Lancet Diabetes Endocrinol. 2023;11:474\u201389. https:\/\/doi.org\/10.1016\/S2213-8587(23)00119-5","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1971_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s13167-023-00314-8","volume":"14","author":"M Kropp","year":"2023","unstructured":"Kropp M, Golubnitschaja O, Mazurakova A, Koklesova L, Sargheini N, Vo T-TKS, de Clerck E, Polivka J, Potuznik P, Polivka J, Stetkarova I, Kubatka P, Thumann G. Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications\u2014risks and mitigation. EPMA J. 2023;14:21\u201342. https:\/\/doi.org\/10.1007\/s13167-023-00314-8","journal-title":"EPMA J"},{"key":"1971_CR3","doi-asserted-by":"publisher","unstructured":"Semeraro F, Cancarini A, dell\u2019Omo R, Rezzola S, Romano MR, Costagliola C. Diabetic retinopathy: vascular and inflammatory disease. J Diabetes Res 2015 (2015) 1\u201316. https:\/\/doi.org\/10.1155\/2015\/582060","DOI":"10.1155\/2015\/582060"},{"key":"1971_CR4","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","volume":"128","author":"ZL Teo","year":"2021","unstructured":"Teo ZL, Tham Y-C, Yu M, Chee ML, Rim TH, Cheung N, Bikbov MM, Wang YX, Tang Y, Lu Y, Wong IY, Ting DSW, Tan GSW, Jonas JB, Sabanayagam C, Wong TY, Cheng C-Y. Global prevalence of diabetic retinopathy and projection of burden through 2045. Ophthalmology. 2021;128:1580\u201391. https:\/\/doi.org\/10.1016\/j.ophtha.2021.04.027","journal-title":"Ophthalmology"},{"key":"1971_CR5","doi-asserted-by":"publisher","unstructured":"Bixler J. Cataracts and their treatment in people with diabetes. ADA Clin Compendia 2019. 2019;6\u201310. https:\/\/doi.org\/10.2337\/db20191-6","DOI":"10.2337\/db20191-6"},{"key":"1971_CR6","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.4103\/ijo.IJO_1158_17","volume":"66","author":"A Kelkar","year":"2018","unstructured":"Kelkar A, Kelkar J, Mehta H, Amoaku W. Cataract surgery in diabetes mellitus: A systematic review. Indian J Ophthalmol. 2018;66:1401\u201310. https:\/\/doi.org\/10.4103\/ijo.IJO_1158_17","journal-title":"Indian J Ophthalmol"},{"key":"1971_CR7","doi-asserted-by":"publisher","first-page":"6317","DOI":"10.3390\/ijms24076317","volume":"24","author":"M Mrugacz","year":"2023","unstructured":"Mrugacz M, Pony-Uram M, Bryl A, Zorena K. Current approach to the pathogenesis of diabetic cataracts. Int J Mol Sci. 2023;24:6317. https:\/\/doi.org\/10.3390\/ijms24076317","journal-title":"Int J Mol Sci"},{"key":"1971_CR8","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/eye.2013.107","volume":"27","author":"K Ghasemi Falavarjani","year":"2013","unstructured":"Ghasemi Falavarjani K, Nguyen QD. Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature. Eye. 2013;27:787\u201394. https:\/\/doi.org\/10.1038\/eye.2013.107","journal-title":"Eye"},{"key":"1971_CR9","doi-asserted-by":"publisher","unstructured":"Liu LC, Chen YH, Lu DW. Overview of recent advances in Nano-Based ocular drug delivery. Int J Mol Sci. 2023;24. https:\/\/doi.org\/10.3390\/ijms242015352","DOI":"10.3390\/ijms242015352"},{"key":"1971_CR10","doi-asserted-by":"publisher","first-page":"16485","DOI":"10.1039\/c8nr00058a","volume":"10","author":"B Mahaling","year":"2018","unstructured":"Mahaling B, Srinivasarao DA, Raghu G, Kasam RK, Bhanuprakash Reddy G, Katti DS. A non-invasive nanoparticle mediated delivery of triamcinolone acetonide ameliorates diabetic retinopathy in rats. Nanoscale. 2018;10:16485\u201398. https:\/\/doi.org\/10.1039\/c8nr00058a","journal-title":"Nanoscale"},{"key":"1971_CR11","doi-asserted-by":"publisher","unstructured":"Srinivasarao DA, Lohiya G, Katti DS. Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases. WIREs Nanomed Nanobiotechnol. 2019;11. https:\/\/doi.org\/10.1002\/wnan.1548","DOI":"10.1002\/wnan.1548"},{"key":"1971_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12951-020-00745-9","volume":"19","author":"S Swetledge","year":"2021","unstructured":"Swetledge S, Jung JP, Carter R, Sabliov C. Distribution of polymeric nanoparticles in the eye: implications in ocular disease therapy. J Nanobiotechnol. 2021;19:10. https:\/\/doi.org\/10.1186\/s12951-020-00745-9","journal-title":"J Nanobiotechnol"},{"key":"1971_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.07.001","volume":"49","author":"KM Meek","year":"2015","unstructured":"Meek KM, Knupp C. Corneal structure and transparency. Prog Retin Eye Res. 2015;49:1\u201316. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.07.001","journal-title":"Prog Retin Eye Res"},{"key":"1971_CR14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4103\/ijo.IJO_646_17","volume":"66","author":"M Sridhar","year":"2018","unstructured":"Sridhar M. Anatomy of cornea and ocular surface. Indian J Ophthalmol. 2018;66:190. https:\/\/doi.org\/10.4103\/ijo.IJO_646_17","journal-title":"Indian J Ophthalmol"},{"key":"1971_CR15","doi-asserted-by":"publisher","unstructured":"Cholkar K, Dasari SR, Pal D, Mitra AK. Eye: anatomy, physiology and barriers to drug delivery, in: Ocular Transporters and Receptors, Elsevier, 2013: pp. 1\u201336. https:\/\/doi.org\/10.1533\/9781908818317.1","DOI":"10.1533\/9781908818317.1"},{"key":"1971_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejps.2018.03.034","volume":"119","author":"E Ramsay","year":"2018","unstructured":"Ramsay E, del Amo EM, Toropainen E, Tengvall-Unadike U, Ranta V-P, Urtti A, Ruponen M. Corneal and conjunctival drug permeability: systematic comparison and Pharmacokinetic impact in the eye. Eur J Pharm Sci. 2018;119:83\u20139. https:\/\/doi.org\/10.1016\/j.ejps.2018.03.034","journal-title":"Eur J Pharm Sci"},{"key":"1971_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.brainres.2007.03.043","volume":"1192","author":"N Davis-Silberman","year":"2008","unstructured":"Davis-Silberman N, Ashery-Padan R. Iris development in vertebrates; genetic and molecular considerations. Brain Res. 2008;1192:17\u201328. https:\/\/doi.org\/10.1016\/j.brainres.2007.03.043","journal-title":"Brain Res"},{"key":"1971_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2016.01.053","volume":"501","author":"B Mahaling","year":"2016","unstructured":"Mahaling B, Katti DS. Understanding the influence of surface properties of nanoparticles and penetration enhancers for improving bioavailability in eye tissues in vivo. Int J Pharm. 2016;501:1\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.01.053","journal-title":"Int J Pharm"},{"key":"1971_CR19","unstructured":"Aliancy JF, Mamalis N. Crystalline Lens and Cataract, 1995."},{"key":"1971_CR20","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.3390\/ijms18122693","volume":"18","author":"K Schey","year":"2017","unstructured":"Schey K, Petrova R, Gletten R, Donaldson P. The role of Aquaporins in ocular lens homeostasis. Int J Mol Sci. 2017;18:2693. https:\/\/doi.org\/10.3390\/ijms18122693","journal-title":"Int J Mol Sci"},{"key":"1971_CR21","doi-asserted-by":"publisher","unstructured":"Remington LA. Ocular adnexa and lacrimal system. Clinical anatomy and physiology of the visual system. Elsevier; 2012. pp. 159\u201381. https:\/\/doi.org\/10.1016\/B978-1-4377-1926-0.10009-8","DOI":"10.1016\/B978-1-4377-1926-0.10009-8"},{"key":"1971_CR22","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/ACI.0b013e3283645899","volume":"13","author":"F Mantelli","year":"2013","unstructured":"Mantelli F, Mauris J, Arg\u00fceso P. The ocular surface epithelial barrier and other mechanisms of mucosal protection. Curr Opin Allergy Clin Immunol. 2013;13:563\u20138. https:\/\/doi.org\/10.1097\/ACI.0b013e3283645899","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"1971_CR23","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jconrel.2023.01.018","volume":"354","author":"AL Onugwu","year":"2023","unstructured":"Onugwu AL, Nwagwu CS, Onugwu OS, Echezona AC, Agbo CP, Ihim SA, Emeh P, Nnamani PO, Attama AA, Khutoryanskiy VV. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases. J Controlled Release. 2023;354:465\u201388. https:\/\/doi.org\/10.1016\/j.jconrel.2023.01.018","journal-title":"J Controlled Release"},{"key":"1971_CR24","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.preteyeres.2009.12.002","volume":"29","author":"DL Nickla","year":"2010","unstructured":"Nickla DL, Wallman J. The multifunctional choroid. Prog Retin Eye Res. 2010;29:144\u201368. https:\/\/doi.org\/10.1016\/j.preteyeres.2009.12.002","journal-title":"Prog Retin Eye Res"},{"key":"1971_CR25","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.3390\/jcm12082870","volume":"12","author":"S Hammadi","year":"2023","unstructured":"Hammadi S, Tzoumas N, Ferrara M, Meschede IP, Lo K, Harris C, Lako M, Steel DH. Bruch\u2019s membrane: A key consideration with Complement-Based therapies for Age-Related macular degeneration. J Clin Med. 2023;12:2870. https:\/\/doi.org\/10.3390\/jcm12082870","journal-title":"J Clin Med"},{"key":"1971_CR26","doi-asserted-by":"publisher","unstructured":"Srinivasarao DA, Lohiya G, Katti DS. Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019;11. https:\/\/doi.org\/10.1002\/wnan.1548","DOI":"10.1002\/wnan.1548"},{"key":"1971_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.addr.2017.04.001","volume":"122","author":"DR Janagam","year":"2017","unstructured":"Janagam DR, Wu L, Lowe TL. Nanoparticles for drug delivery to the anterior segment of the eye. Adv Drug Deliv Rev. 2017;122:31\u201364. https:\/\/doi.org\/10.1016\/j.addr.2017.04.001","journal-title":"Adv Drug Deliv Rev"},{"key":"1971_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3390\/ijms21010211","volume":"21","author":"A Naylor","year":"2019","unstructured":"Naylor A, Hopkins A, Hudson N, Campbell M. Tight junctions of the outer blood retina barrier. Int J Mol Sci. 2019;21:211. https:\/\/doi.org\/10.3390\/ijms21010211","journal-title":"Int J Mol Sci"},{"key":"1971_CR29","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1167\/iovs.19-28632","volume":"60","author":"JY Niederkorn","year":"2019","unstructured":"Niederkorn JY. The eye sees eye to eye with the immune system: the 2019 proctor lecture. Invest Opthalmology Visual Sci. 2019;60:4489. https:\/\/doi.org\/10.1167\/iovs.19-28632","journal-title":"Invest Opthalmology Visual Sci"},{"key":"1971_CR30","doi-asserted-by":"publisher","unstructured":"Wang Y, Gao S, Cao F, Yang H, Lei F, Hou S. Ocular immune-related diseases: molecular mechanisms and therapy. MedComm (Beijing). 2024;5. https:\/\/doi.org\/10.1002\/mco2.70021","DOI":"10.1002\/mco2.70021"},{"key":"1971_CR31","doi-asserted-by":"publisher","first-page":"100940","DOI":"10.1016\/j.preteyeres.2021.100940","volume":"84","author":"WW Pan","year":"2021","unstructured":"Pan WW, Lin F, Fort PE. The innate immune system in diabetic retinopathy. Prog Retin Eye Res. 2021;84:100940. https:\/\/doi.org\/10.1016\/j.preteyeres.2021.100940","journal-title":"Prog Retin Eye Res"},{"key":"1971_CR32","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nri3459","volume":"13","author":"J Ambati","year":"2013","unstructured":"Ambati J, Atkinson JP, Gelfand BD. Immunology of age-related macular degeneration. Nat Rev Immunol. 2013;13:438\u201351. https:\/\/doi.org\/10.1038\/nri3459","journal-title":"Nat Rev Immunol"},{"key":"1971_CR33","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jconrel.2013.09.013","volume":"172","author":"MJ Ernsting","year":"2013","unstructured":"Ernsting MJ, Murakami M, Roy A, Li S-D. Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. J Control Release. 2013;172:782\u201394. https:\/\/doi.org\/10.1016\/j.jconrel.2013.09.013","journal-title":"J Control Release"},{"key":"1971_CR34","doi-asserted-by":"publisher","first-page":"152317","DOI":"10.1016\/j.imbio.2022.152317","volume":"228","author":"K Pondman","year":"2023","unstructured":"Pondman K, Le Gac S, Kishore U. Nanoparticle-induced immune response: health risk versus treatment opportunity? Immunobiology. 2023;228:152317. https:\/\/doi.org\/10.1016\/j.imbio.2022.152317","journal-title":"Immunobiology"},{"key":"1971_CR35","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1211\/jpp.57.12.0005","volume":"57","author":"AC Amrite","year":"2005","unstructured":"Amrite AC, Kompella UB. Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration. J Pharm Pharmacol. 2005;57:1555\u201363. https:\/\/doi.org\/10.1211\/jpp.57.12.0005","journal-title":"J Pharm Pharmacol"},{"key":"1971_CR36","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.ijbiomac.2014.10.014","volume":"72","author":"YS Chhonker","year":"2015","unstructured":"Chhonker YS, Prasad YD, Chandasana H, Vishvkarma A, Mitra K, Shukla PK, Bhatta RS. Amphotericin-B entrapped lecithin\/chitosan nanoparticles for prolonged ocular application. Int J Biol Macromol. 2015;72:1451\u20138. https:\/\/doi.org\/10.1016\/j.ijbiomac.2014.10.014","journal-title":"Int J Biol Macromol"},{"key":"1971_CR37","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.1021\/acs.molpharmaceut.2c00341","volume":"19","author":"N Li","year":"2022","unstructured":"Li N, Zhao Z, Ma H, Liu Y, Nwafor E-O, Zhu S, Jia L, Pang X, Han Z, Tian B, Pan H, Liu Z, Pan W. Optimization and characterization of Low-Molecular-Weight Chitosan-Coated Baicalin mPEG-PLGA nanoparticles for the treatment of cataract. Mol Pharm. 2022;19:3831\u201345. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.2c00341","journal-title":"Mol Pharm"},{"key":"1971_CR38","doi-asserted-by":"publisher","first-page":"12270","DOI":"10.1038\/s41598-021-90792-5","volume":"11","author":"S Swetledge","year":"2021","unstructured":"Swetledge S, Carter R, Stout R, Astete CE, Jung JP, Sabliov CM. Stability and ocular biodistribution of topically administered PLGA nanoparticles. Sci Rep. 2021;11:12270. https:\/\/doi.org\/10.1038\/s41598-021-90792-5","journal-title":"Sci Rep"},{"key":"1971_CR39","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ijpharm.2018.12.057","volume":"557","author":"Z Wen","year":"2019","unstructured":"Wen Z, Muratomi N, Huang W, Huang L, Ren J, Yang J, Persaud Y, Loloi J, Mallangada N, Kung P, Honkanen R, Rigas B. The ocular pharmacokinetics and biodistribution of phospho-sulindac (OXT-328) formulated in nanoparticles: enhanced and targeted tissue drug delivery. Int J Pharm. 2019;557:273\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.12.057","journal-title":"Int J Pharm"},{"key":"1971_CR40","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.biopha.2017.07.110","volume":"94","author":"MA Kalam","year":"2017","unstructured":"Kalam MA, Alshamsan A. Poly (d, l-lactide-co-glycolide) nanoparticles for sustained release of tacrolimus in rabbit eyes. Biomed Pharmacother. 2017;94:402\u201311. https:\/\/doi.org\/10.1016\/j.biopha.2017.07.110","journal-title":"Biomed Pharmacother"},{"key":"1971_CR41","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/j.nano.2016.05.017","volume":"12","author":"B Mahaling","year":"2016","unstructured":"Mahaling B, Katti DS. Physicochemical properties of core\u2013shell type nanoparticles govern their Spatiotemporal biodistribution in the eye. Nanomedicine. 2016;12:2149\u201360. https:\/\/doi.org\/10.1016\/j.nano.2016.05.017","journal-title":"Nanomedicine"},{"key":"1971_CR42","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3390\/ph14050480","volume":"14","author":"M Kallab","year":"2021","unstructured":"Kallab M, Schuetzenberger K, Hommer N, Sch\u00e4fer BJ, Schmidl D, Bergmeister H, Zeitlinger M, Tan A, Jansook P, Loftsson T, Stefansson E, Garh\u00f6fer G. Bio-Distribution and pharmacokinetics of topically administered \u03b3-Cyclodextrin based eye drops in rabbits. Pharmaceuticals. 2021;14:480. https:\/\/doi.org\/10.3390\/ph14050480","journal-title":"Pharmaceuticals"},{"key":"1971_CR43","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/s41598-023-28845-0","volume":"13","author":"B Silva","year":"2023","unstructured":"Silva B, Gon\u00e7alves LM, S\u00e3o Braz B, Delgado E. Topical ocular delivery of nanoparticles with Epoetin beta in Wistar Hannover rats. Sci Rep. 2023;13:1559. https:\/\/doi.org\/10.1038\/s41598-023-28845-0","journal-title":"Sci Rep"},{"key":"1971_CR44","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.actbio.2020.01.008","volume":"104","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhou L, Fang L, Cao F. Multifunctional carboxymethyl Chitosan derivatives-layered double hydroxide hybrid nanocomposites for efficient drug delivery to the posterior segment of the eye. Acta Biomater. 2020;104:104\u201314. https:\/\/doi.org\/10.1016\/j.actbio.2020.01.008","journal-title":"Acta Biomater"},{"key":"1971_CR45","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1080\/10717544.2019.1667455","volume":"26","author":"X Yang","year":"2019","unstructured":"Yang X, Wang L, Li L, Han M, Tang S, Wang T, Han J, He X, He X, Wang A, Sun K. A novel dendrimer-based complex co-modified with Cyclic RGD hexapeptide and penetratin for noninvasive targeting and penetration of the ocular posterior segment. Drug Deliv. 2019;26:989\u20131001. https:\/\/doi.org\/10.1080\/10717544.2019.1667455","journal-title":"Drug Deliv"},{"key":"1971_CR46","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/pharmaceutics14010134","volume":"14","author":"M L\u00f6scher","year":"2022","unstructured":"L\u00f6scher M, Seiz C, Hurst J, Schnichels S. Topical drug delivery to the posterior segment of the eye. Pharmaceutics. 2022;14:134. https:\/\/doi.org\/10.3390\/pharmaceutics14010134","journal-title":"Pharmaceutics"},{"key":"1971_CR47","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.apsb.2016.09.001","volume":"7","author":"Y Weng","year":"2017","unstructured":"Weng Y, Liu J, Jin S, Guo W, Liang X, Hu Z. Nanotechnology-based strategies for treatment of ocular disease. Acta Pharm Sin B. 2017;7:281\u201391. https:\/\/doi.org\/10.1016\/j.apsb.2016.09.001","journal-title":"Acta Pharm Sin B"},{"key":"1971_CR48","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s13346-016-0339-2","volume":"6","author":"V Agrahari","year":"2016","unstructured":"Agrahari V, Mandal A, Agrahari V, Trinh HM, Joseph M, Ray A, Hadji H, Mitra R, Pal D, Mitra AK. A comprehensive insight on ocular pharmacokinetics. Drug Deliv Transl Res. 2016;6:735\u201354. https:\/\/doi.org\/10.1007\/s13346-016-0339-2","journal-title":"Drug Deliv Transl Res"},{"key":"1971_CR49","doi-asserted-by":"publisher","unstructured":"L\u00f6scher M, Seiz C, Hurst J, Schnichels S. Topical drug delivery to the posterior segment of the eye. Pharmaceutics. 2022;14. https:\/\/doi.org\/10.3390\/pharmaceutics14010134","DOI":"10.3390\/pharmaceutics14010134"},{"key":"1971_CR50","doi-asserted-by":"publisher","unstructured":"Dosmar E, Walsh J, Doyel M, Bussett K, Oladipupo A, Amer S, Goebel K. Targeting ocular drug delivery: an examination of local anatomy and current approaches. Bioeng (Basel). 2022;9. https:\/\/doi.org\/10.3390\/bioengineering9010041","DOI":"10.3390\/bioengineering9010041"},{"key":"1971_CR51","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","volume":"12","author":"R Gaudana","year":"2010","unstructured":"Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery. AAPS J. 2010;12:348\u201360. https:\/\/doi.org\/10.1208\/s12248-010-9183-3","journal-title":"AAPS J"},{"key":"1971_CR52","doi-asserted-by":"publisher","first-page":"120924","DOI":"10.1016\/j.ijpharm.2021.120924","volume":"607","author":"M Mofidfar","year":"2021","unstructured":"Mofidfar M, Abdi B, Ahadian S, Mostafavi E, Desai TA, Abbasi F, Sun Y, Manche EE, Ta CN, Flowers CW. Drug delivery to the anterior segment of the eye: A review of current and future treatment strategies. Int J Pharm. 2021;607:120924. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120924","journal-title":"Int J Pharm"},{"key":"1971_CR53","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1016\/j.biomaterials.2012.01.030","volume":"33","author":"H Koo","year":"2012","unstructured":"Koo H, Moon H, Han H, Na JH, Huh MS, Park JH, Woo SJ, Park KH, Chan Kwon I, Kim K, Kim H. The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection. Biomaterials. 2012;33:3485\u201393. https:\/\/doi.org\/10.1016\/j.biomaterials.2012.01.030","journal-title":"Biomaterials"},{"key":"1971_CR54","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.3390\/ijms19092830","volume":"19","author":"C-H Tsai","year":"2018","unstructured":"Tsai C-H, Wang P-Y, Lin I-C, Huang H, Liu G-S. Tseng, ocular drug delivery: role of degradable polymeric nanocarriers for ophthalmic application. Int J Mol Sci. 2018;19:2830. https:\/\/doi.org\/10.3390\/ijms19092830","journal-title":"Int J Mol Sci"},{"key":"1971_CR55","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1111\/bph.14024","volume":"174","author":"S Awwad","year":"2017","unstructured":"Awwad S, Mohamed Ahmed AHA, Sharma G, Heng JS, Khaw PT, Brocchini S, Lockwood A. Principles of Pharmacology in the eye. Br J Pharmacol. 2017;174:4205\u201323. https:\/\/doi.org\/10.1111\/bph.14024","journal-title":"Br J Pharmacol"},{"key":"1971_CR56","first-page":"1181","volume":"41","author":"J Ambati","year":"2000","unstructured":"Ambati J, Canakis CS, Miller JW, Gragoudas ES, Edwards A, Weissgold DJ, Kim I, Delori FC, Adamis AP. Diffusion of high molecular weight compounds through sclera. Invest Ophthalmol Vis Sci. 2000;41:1181\u20135.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1971_CR57","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/pharmaceutics14010090","volume":"14","author":"L Bonilla","year":"2021","unstructured":"Bonilla L, Espina M, Severino P, Cano A, Ettcheto M, Camins A, Garc\u00eda ML, Souto EB. S\u00e1nchez-L\u00f3pez, lipid nanoparticles for the posterior eye segment. Pharmaceutics. 2021;14:90. https:\/\/doi.org\/10.3390\/pharmaceutics14010090","journal-title":"Pharmaceutics"},{"key":"1971_CR58","doi-asserted-by":"publisher","first-page":"4513","DOI":"10.1167\/iovs.06-0404","volume":"47","author":"NPS Cheruvu","year":"2006","unstructured":"Cheruvu NPS, Kompella UB. Bovine and Porcine transscleral solute transport: influence of lipophilicity and the Choroid\u2013Bruch\u2019s layer. Invest Opthalmology Visual Sci. 2006;47:4513. https:\/\/doi.org\/10.1167\/iovs.06-0404","journal-title":"Invest Opthalmology Visual Sci"},{"key":"1971_CR59","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","volume":"58","author":"A Urtti","year":"2006","unstructured":"Urtti A. Challenges and Obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev. 2006;58:1131\u20135. https:\/\/doi.org\/10.1016\/j.addr.2006.07.027","journal-title":"Adv Drug Deliv Rev"},{"key":"1971_CR60","doi-asserted-by":"publisher","first-page":"e23810","DOI":"10.1016\/j.heliyon.2023.e23810","volume":"10","author":"S Ashique","year":"2024","unstructured":"Ashique S, Mishra N, Mohanto S, Gowda BHJ, Kumar S, Raikar AS, Masand P, Garg A, Goswami P, Kahwa I. Overview of processed excipients in ocular drug delivery: opportunities so Far and bottlenecks. Heliyon. 2024;10:e23810. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23810","journal-title":"Heliyon"},{"key":"1971_CR61","doi-asserted-by":"publisher","first-page":"5978","DOI":"10.1016\/j.biomaterials.2013.04.035","volume":"34","author":"L Gan","year":"2013","unstructured":"Gan L, Wang J, Zhao Y, Chen D, Zhu C, Liu J, Gan Y. Hyaluronan-modified core\u2013shell liponanoparticles targeting CD44-positive retinal pigment epithelium cells via intravitreal injection. Biomaterials. 2013;34:5978\u201387. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.04.035","journal-title":"Biomaterials"},{"key":"1971_CR62","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1021\/nn305958y","volume":"7","author":"L Luo","year":"2013","unstructured":"Luo L, Zhang X, Hirano Y, Tyagi P, Barab\u00e1s P, Uehara H, Miya TR, Singh N, Archer B, Qazi Y, Jackman K, Das SK, Olsen T, Chennamaneni SR, Stagg BC, Ahmed F, Emerson L, Zygmunt K, Whitaker R, Mamalis C, Huang W, Gao G, Srinivas SP, Krizaj D, Baffi J, Ambati J, Kompella UB. Ambati, targeted intraceptor nanoparticle therapy reduces angiogenesis and fibrosis in primate and murine macular degeneration. ACS Nano. 2013;7:3264\u201375. https:\/\/doi.org\/10.1021\/nn305958y","journal-title":"ACS Nano"},{"key":"1971_CR63","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1166\/jbn.2021.3073","volume":"17","author":"M Tawfik","year":"2021","unstructured":"Tawfik M, Hadlak S, G\u00f6tze C, Sokolov M, Kulikov P, Kuskov A, Shtilman M, Sabel BA, Henrich-Noack P. Live In-Vivo neuroimaging reveals the transport of lipophilic cargo through the Blood-Retina barrier with modified amphiphilic Poly-N-Vinylpyrrolidone nanoparticles. J Biomed Nanotechnol. 2021;17:846\u201358. https:\/\/doi.org\/10.1166\/jbn.2021.3073","journal-title":"J Biomed Nanotechnol"},{"key":"1971_CR64","doi-asserted-by":"publisher","first-page":"505101","DOI":"10.1088\/0957-4484\/20\/50\/505101","volume":"20","author":"JH Kim","year":"2009","unstructured":"Kim JH, Kim JH, Kim K-W, Kim MH, Yu YS. Intravenously administered gold nanoparticles pass through the blood\u2013retinal barrier depending on the particle size, and induce no retinal toxicity. Nanotechnology. 2009;20:505101. https:\/\/doi.org\/10.1088\/0957-4484\/20\/50\/505101","journal-title":"Nanotechnology"},{"key":"1971_CR65","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.biopha.2018.08.138","volume":"107","author":"K Nayak","year":"2018","unstructured":"Nayak K, Misra M. A review on recent drug delivery systems for posterior segment of eye. Biomed Pharmacother. 2018;107:1564\u201382. https:\/\/doi.org\/10.1016\/j.biopha.2018.08.138","journal-title":"Biomed Pharmacother"},{"key":"1971_CR66","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jconrel.2013.01.018","volume":"167","author":"Q Xu","year":"2013","unstructured":"Xu Q, Boylan NJ, Suk JS, Wang Y-Y, Nance EA, Yang J-C, McDonnell PJ, Cone RA, Duh EJ, Hanes J. Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo. J Controlled Release. 2013;167:76\u201384. https:\/\/doi.org\/10.1016\/j.jconrel.2013.01.018","journal-title":"J Controlled Release"},{"key":"1971_CR67","doi-asserted-by":"publisher","first-page":"103955","DOI":"10.1016\/j.compbiomed.2020.103955","volume":"125","author":"J Bayat","year":"2020","unstructured":"Bayat J, Emdad H, Abouali O. 3D numerical investigation of the fluid mechanics in a partially liquefied vitreous humor due to saccadic eye movement. Comput Biol Med. 2020;125:103955. https:\/\/doi.org\/10.1016\/j.compbiomed.2020.103955","journal-title":"Comput Biol Med"},{"key":"1971_CR68","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1080\/02713683.2020.1826977","volume":"46","author":"NK Tram","year":"2021","unstructured":"Tram NK, Maxwell CJ, Swindle-Reilly KE. Macro- and microscale properties of the vitreous humor to inform substitute design and intravitreal Biotransport. Curr Eye Res. 2021;46:429\u201344. https:\/\/doi.org\/10.1080\/02713683.2020.1826977","journal-title":"Curr Eye Res"},{"key":"1971_CR69","doi-asserted-by":"publisher","unstructured":"Manik Goel Renata G Picciani Richard K Lee and Sanjoy K Bhattacharya; Aqueous Humor Dynamics: A Review; The Open Ophthalmology Journal; 4. (2010) 52\u201359. https:\/\/doi.org\/10.2174\/1874364101004010052","DOI":"10.2174\/1874364101004010052"},{"key":"1971_CR70","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1023\/A:1007517912927","volume":"17","author":"J Xu","year":"2000","unstructured":"Xu J, Heys JJ, Barocas VH, Randolph TW. Permeability and diffusion in vitreous humor: implications for drug delivery. Pharm Res. 2000;17:664\u20139. https:\/\/doi.org\/10.1023\/A:1007517912927","journal-title":"Pharm Res"},{"key":"1971_CR71","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/pharmaceutics12030269","volume":"12","author":"R Varela-Fern\u00e1ndez","year":"2020","unstructured":"Varela-Fern\u00e1ndez R, D\u00edaz-Tom\u00e9 V, Luaces-Rodr\u00edguez A, Conde-Penedo A, Garc\u00eda-Otero X, Luzardo-\u00c1lvarez A, Fern\u00e1ndez-Ferreiro A, Otero-Espinar F. Drug delivery to the posterior segment of the eye: biopharmaceutic and Pharmacokinetic considerations. Pharmaceutics. 2020;12:269. https:\/\/doi.org\/10.3390\/pharmaceutics12030269","journal-title":"Pharmaceutics"},{"key":"1971_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/148039","volume":"2012","author":"M Angi","year":"2012","unstructured":"Angi M, Kalirai H, Coupland SE, Damato BE, Semeraro F, Romano MR. Proteomic analyses of the vitreous humour. Mediators Inflamm. 2012;2012:1\u20137. https:\/\/doi.org\/10.1155\/2012\/148039","journal-title":"Mediators Inflamm"},{"key":"1971_CR73","doi-asserted-by":"publisher","first-page":"10727","DOI":"10.1039\/C8NR08305C","volume":"11","author":"A Ghazaryan","year":"2019","unstructured":"Ghazaryan A, Landfester K, Mail\u00e4nder V. Protein deglycosylation can drastically affect the cellular uptake. Nanoscale. 2019;11:10727\u201337. https:\/\/doi.org\/10.1039\/C8NR08305C","journal-title":"Nanoscale"},{"key":"1971_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijbiomac.2021.01.152","volume":"175","author":"RK Mishra","year":"2021","unstructured":"Mishra RK, Ahmad A, Vyawahare A, Alam P, Khan TH, Khan R. Biological effects of formation of protein Corona onto nanoparticles. Int J Biol Macromol. 2021;175:1\u201318. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.01.152","journal-title":"Int J Biol Macromol"},{"key":"1971_CR75","doi-asserted-by":"publisher","first-page":"11773","DOI":"10.1021\/acsnano.7b08008","volume":"11","author":"PC Ke","year":"2017","unstructured":"Ke PC, Lin S, Parak WJ, Davis TP, Caruso F. A decade of the protein Corona. ACS Nano. 2017;11:11773\u20136. https:\/\/doi.org\/10.1021\/acsnano.7b08008","journal-title":"ACS Nano"},{"key":"1971_CR76","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.biomaterials.2018.03.034","volume":"168","author":"D Huang","year":"2018","unstructured":"Huang D, Chen Y-S, Green CR, Rupenthal ID. Hyaluronic acid coated albumin nanoparticles for targeted peptide delivery in the treatment of retinal ischaemia. Biomaterials. 2018;168:10\u201323. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.03.034","journal-title":"Biomaterials"},{"key":"1971_CR77","doi-asserted-by":"publisher","unstructured":"Yu Q, Zhao L, Guo C, Yan B, Su G. Regulating protein Corona formation and dynamic protein exchange by controlling nanoparticle hydrophobicity. Front Bioeng Biotechnol. 2020;8. https:\/\/doi.org\/10.3389\/fbioe.2020.00210","DOI":"10.3389\/fbioe.2020.00210"},{"key":"1971_CR78","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/tcr.202000042","volume":"21","author":"S Skalickova","year":"2021","unstructured":"Skalickova S, Horky P, Mlejnkova V, Skladanka J, Hosnedlova B, Ruttkay-Nedecky B, Fernandez C, Kizek R. Theranostic approach for the protein Corona of polysaccharide nanoparticles. Chem Record. 2021;21:17\u201328. https:\/\/doi.org\/10.1002\/tcr.202000042","journal-title":"Chem Record"},{"key":"1971_CR79","doi-asserted-by":"publisher","first-page":"128513","DOI":"10.1016\/j.ijbiomac.2023.128513","volume":"256","author":"F Guo","year":"2024","unstructured":"Guo F, Luo S, Wang L, Wang M, Wu F, Wang Y, Jiao Y, Du Y, Yang Q, Yang X, Yang G. Protein corona, influence on drug delivery system and its improvement strategy: A review. Int J Biol Macromol. 2024;256:128513. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.128513","journal-title":"Int J Biol Macromol"},{"key":"1971_CR80","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1080\/02713683.2022.2119254","volume":"48","author":"D Mishra","year":"2023","unstructured":"Mishra D, Gade S, Glover K, Sheshala R, Singh TRR. Vitreous humor: composition, characteristics and implication on intravitreal drug delivery. Curr Eye Res. 2023;48:208\u201318. https:\/\/doi.org\/10.1080\/02713683.2022.2119254","journal-title":"Curr Eye Res"},{"key":"1971_CR81","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1167\/iovs.10-5813","volume":"52","author":"LE Tan","year":"2011","unstructured":"Tan LE, Orilla W, Hughes PM, Tsai S, Burke JA, Wilson CG. Effects of vitreous liquefaction on the intravitreal distribution of sodium fluorescein, fluorescein dextran, and fluorescent microparticles. Invest Opthalmology Visual Sci. 2011;52:1111. https:\/\/doi.org\/10.1167\/iovs.10-5813","journal-title":"Invest Opthalmology Visual Sci"},{"key":"1971_CR82","doi-asserted-by":"publisher","unstructured":"Penkova A, Moats R, Humayun MS, Fraser S, Sadhal SS. Diffusive transport in the vitreous humor: experimental and analytical studies. J Heat Transf. 2019;141. https:\/\/doi.org\/10.1115\/1.4042297","DOI":"10.1115\/1.4042297"},{"key":"1971_CR83","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.3174\/ajnr.A2543","volume":"32","author":"\u0130 Meral","year":"2011","unstructured":"Meral \u0130, Bilgili Y. Diffusion changes in the vitreous humor of the eye during aging. Am J Neuroradiol. 2011;32:1563\u20136. https:\/\/doi.org\/10.3174\/ajnr.A2543","journal-title":"Am J Neuroradiol"},{"key":"1971_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2023.07.028","volume":"361","author":"E Ramsay","year":"2023","unstructured":"Ramsay E, Lajunen T, Bhattacharya M, Reinisalo M, Rilla K, Kidron H, Terasaki T, Urtti A. Selective drug delivery to the retinal cells: biological barriers and avenues. J Controlled Release. 2023;361:1\u201319. https:\/\/doi.org\/10.1016\/j.jconrel.2023.07.028","journal-title":"J Controlled Release"},{"key":"1971_CR85","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/eye.1990.41","volume":"4","author":"P T\u00f6rnquist","year":"1990","unstructured":"T\u00f6rnquist P, Alm A, Bill A. Permeability of ocular vessels and transport across the blood-retinal-barrier. Eye. 1990;4:303\u20139. https:\/\/doi.org\/10.1038\/eye.1990.41","journal-title":"Eye"},{"key":"1971_CR86","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","volume":"57","author":"EM del Amo","year":"2017","unstructured":"del Amo EM, Rimpel\u00e4 A-K, Heikkinen E, Kari OK, Ramsay E, Lajunen T, Schmitt M, Pelkonen L, Bhattacharya M, Richardson D, Subrizi A, Turunen T, Reinisalo M, Itkonen J, Toropainen E, Casteleijn M, Kidron H, Antopolsky M, Vellonen K-S, Ruponen M, Urtti A. Pharmacokinetic aspects of retinal drug delivery. Prog Retin Eye Res. 2017;57:134\u201385. https:\/\/doi.org\/10.1016\/j.preteyeres.2016.12.001","journal-title":"Prog Retin Eye Res"},{"key":"1971_CR87","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.exer.2015.05.003","volume":"137","author":"EM del Amo","year":"2015","unstructured":"del Amo EM, Urtti A. Rabbit as an animal model for intravitreal pharmacokinetics: clinical predictability and quality of the published data. Exp Eye Res. 2015;137:111\u201324. https:\/\/doi.org\/10.1016\/j.exer.2015.05.003","journal-title":"Exp Eye Res"},{"key":"1971_CR88","doi-asserted-by":"publisher","unstructured":"Lutty GA. Effects of diabetes on the eye. Invest Ophthalmol Vis Sci. 2013;54. https:\/\/doi.org\/10.1167\/iovs.13-12979","DOI":"10.1167\/iovs.13-12979"},{"key":"1971_CR89","unstructured":"Shukla UV, Tripathy K, Retinopathy D. Treasure Island (FL): StatPearls Publishing (2024)."},{"key":"1971_CR90","doi-asserted-by":"publisher","first-page":"364","DOI":"10.4093\/dmj.2018.0182","volume":"42","author":"S Kusuhara","year":"2018","unstructured":"Kusuhara S, Fukushima Y, Ogura S, Inoue N, Uemura A. Pathophysiology of diabetic retinopathy: the old and the new. Diabetes Metab J. 2018;42:364. https:\/\/doi.org\/10.4093\/dmj.2018.0182","journal-title":"Diabetes Metab J"},{"key":"1971_CR91","doi-asserted-by":"publisher","unstructured":"Yang Z, Tan T-E, Shao Y, Wong TY, Li X. Classification of diabetic retinopathy: past, present and future. Front Endocrinol (Lausanne). 2022;13. https:\/\/doi.org\/10.3389\/fendo.2022.1079217","DOI":"10.3389\/fendo.2022.1079217"},{"key":"1971_CR92","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4103\/0301-4738.37603","volume":"56","author":"R Singh","year":"2008","unstructured":"Singh R, Ramasamy K, Abraham C, Gupta V, Gupta A. Diabetic retinopathy: an update. Indian J Ophthalmol. 2008;56:178\u201388.","journal-title":"Indian J Ophthalmol"},{"key":"1971_CR93","doi-asserted-by":"publisher","unstructured":"Waheed NK. Diabetic Macular Edema, in: Atlas of Retinal OCT: Optical Coherence Tomography, Elsevier, 2018: pp. 84\u201385. https:\/\/doi.org\/10.1016\/B978-0-323-46121-4.00037-6","DOI":"10.1016\/B978-0-323-46121-4.00037-6"},{"key":"1971_CR94","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4239\/wjd.v6.i1.92","volume":"6","author":"N Sayin","year":"2015","unstructured":"Sayin N. Ocular complications of diabetes mellitus. World J Diabetes. 2015;6:92. https:\/\/doi.org\/10.4239\/wjd.v6.i1.92","journal-title":"World J Diabetes"},{"key":"1971_CR95","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1755-3768.1983.tb01439.x","volume":"61","author":"P BERNTH-PETERSEN","year":"1983","unstructured":"BERNTH-PETERSEN P, BACH E, EPIDEMIOLOGIC ASPECTS OF CATARACT, SURGERY. Acta Ophthalmol. 1983;61:406\u201316. https:\/\/doi.org\/10.1111\/j.1755-3768.1983.tb01439.x","journal-title":"Acta Ophthalmol"},{"key":"1971_CR96","unstructured":"Kohli P, Tripathy K, Patel BC, Macular, Edema. Treasure Island (FL): StatPearls Publishing (2024)."},{"key":"1971_CR97","unstructured":"Musat O, Cernat C, Labib M, Gheorghe A, Toma O, Zamfir M, Boureanu AM. DIABETIC MACULAR EDEMA., Rom J Ophthalmol 59 (2015) 133\u20136."},{"key":"1971_CR98","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","volume":"107","author":"F Giacco","year":"2010","unstructured":"Giacco F, Brownlee M, Stress O, Complications D. Circ Res. 2010;107:1058\u201370. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.223545","journal-title":"Circ Res"},{"key":"1971_CR99","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1021\/acsabm.3c01200","volume":"7","author":"S Sarkar","year":"2024","unstructured":"Sarkar S, Osman N, Thrimawithana T, Wann SB, Kalita J, Manna P. Alleviation of diabetic retinopathy by Glucose-Triggered delivery of vitamin D via Dextran-Gated functionalized mesoporous silica nanoparticles. ACS Appl Bio Mater. 2024;7:1260\u201370. https:\/\/doi.org\/10.1021\/acsabm.3c01200","journal-title":"ACS Appl Bio Mater"},{"key":"1971_CR100","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jconrel.2024.07.022","volume":"373","author":"AM Elbedwehy","year":"2024","unstructured":"Elbedwehy AM, Wu J, Na H-K, Baek A, Jung H, Kwon IH, Lee SW, Kim JH, Lee TG. ROS-responsive charge reversal mesoporous silica nanoparticles as promising drug delivery system for neovascular retinal diseases. J Controlled Release. 2024;373:224\u201339. https:\/\/doi.org\/10.1016\/j.jconrel.2024.07.022","journal-title":"J Controlled Release"},{"key":"1971_CR101","doi-asserted-by":"publisher","unstructured":"Ansari P, Tabasumma N, Snigdha NN, Siam NH, Panduru RVNRS, Azam S, Hannan JMA. Y.H.A. Abdel-Wahab, diabetic retinopathy: an overview on mechanisms, pathophysiology and pharmacotherapy, diabetology 3 (2022) 159\u201375. https:\/\/doi.org\/10.3390\/diabetology3010011","DOI":"10.3390\/diabetology3010011"},{"key":"1971_CR102","doi-asserted-by":"publisher","unstructured":"Kaur C. Hypoxia-ischemia and retinal ganglion cell damage. Clin Ophthalmol. 2008;879. https:\/\/doi.org\/10.2147\/OPTH.S3361","DOI":"10.2147\/OPTH.S3361"},{"key":"1971_CR103","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.aopr.2023.10.001","volume":"3","author":"Z Guo","year":"2023","unstructured":"Guo Z, Ma X, Zhang RX, Yan H. Oxidative stress, epigenetic regulation and pathological processes of lens epithelial cells underlying diabetic cataract. Adv Ophthalmol Pract Res. 2023;3:180\u20136. https:\/\/doi.org\/10.1016\/j.aopr.2023.10.001","journal-title":"Adv Ophthalmol Pract Res"},{"key":"1971_CR104","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.exer.2012.05.007","volume":"101","author":"P Zhang","year":"2012","unstructured":"Zhang P, Xing K, Randazzo J, Blessing K, Lou MF, Kador PF. Osmotic stress, not aldose reductase activity, directly induces growth factors and MAPK signaling changes during sugar cataract formation. Exp Eye Res. 2012;101:36\u201343. https:\/\/doi.org\/10.1016\/j.exer.2012.05.007","journal-title":"Exp Eye Res"},{"key":"1971_CR105","doi-asserted-by":"publisher","first-page":"113798","DOI":"10.1016\/j.jconrel.2025.113798","volume":"383","author":"J Wang","year":"2025","unstructured":"Wang J, Zhang R, Xie H, Yang Y, Chen H, Lin Q. Metal-phenolic Epigallocatechin gallate-zinc antioxidant nanoparticles for cataract treatment. J Controlled Release. 2025;383:113798. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113798","journal-title":"J Controlled Release"},{"key":"1971_CR106","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12951-025-03402-1","volume":"23","author":"L Jiang","year":"2025","unstructured":"Jiang L, Liu J, Chen S, Cui W, Guo J, Cheng X, Zheng Y, Yang W, Pan Z, Wang Y, Zhao M, Han H, Yao K, Yu Y. Cyclic cell-penetrating peptide-engineered ceria nanoparticles for non-invasive alleviation of ultraviolet radiation-induced cataract. J Nanobiotechnol. 2025;23:337. https:\/\/doi.org\/10.1186\/s12951-025-03402-1","journal-title":"J Nanobiotechnol"},{"key":"1971_CR107","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2147\/OPTH.S236637","volume":"14","author":"SE Mansour","year":"2020","unstructured":"Mansour SE, Browning DJ, Wong K, Flynn HW Jr, Bhavsar AR. The evolving treatment of diabetic retinopathy. Clin Ophthalmol Volume. 2020;14:653\u201378. https:\/\/doi.org\/10.2147\/OPTH.S236637","journal-title":"Clin Ophthalmol Volume"},{"key":"1971_CR108","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3390\/ph16081140","volume":"16","author":"A Hang","year":"2023","unstructured":"Hang A, Feldman S, Amin AP, Ochoa JAR, Park SS. Intravitreal Anti-Vascular endothelial growth factor therapies for retinal disorders. Pharmaceuticals. 2023;16:1140. https:\/\/doi.org\/10.3390\/ph16081140","journal-title":"Pharmaceuticals"},{"key":"1971_CR109","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1097\/IAE.0000000000003626","volume":"42","author":"PK Kaiser","year":"2022","unstructured":"Kaiser PK, Schmitz-Valckenberg MS, Holz FG, ANTI\u2013VASCULAR ENDOTHELIAL GROWTH FACTOR BIOSIMILARS IN OPHTHALMOLOGY. Retina. 2022;42:2243\u201350. https:\/\/doi.org\/10.1097\/IAE.0000000000003626","journal-title":"Retina"},{"key":"1971_CR110","doi-asserted-by":"publisher","unstructured":"Evans JR, Michelessi M, Virgili G. Laser photocoagulation for proliferative diabetic retinopathy. Cochrane Database Syst Reviews. 2015;2014. https:\/\/doi.org\/10.1002\/14651858.CD011234.pub2","DOI":"10.1002\/14651858.CD011234.pub2"},{"key":"1971_CR111","unstructured":"Omari A, Mahmoud TH, Vitrectomy. Stat Pearls [Internet]. Treasure Island (FL): StatPearls Publishing (2023)."},{"key":"1971_CR112","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.3390\/healthcare9111603","volume":"9","author":"M Ben\u00edtez Mart\u00ednez","year":"2021","unstructured":"Ben\u00edtez Mart\u00ednez M, Baeza Moyano D, Gonz\u00e1lez-Lezcano RA. Phacoemulsification: proposals for improvement in its application. Healthcare. 2021;9:1603. https:\/\/doi.org\/10.3390\/healthcare9111603","journal-title":"Healthcare"},{"key":"1971_CR113","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jsps.2017.10.012","volume":"26","author":"SAA Rizvi","year":"2018","unstructured":"Rizvi SAA, Saleh AM. Applications of nanoparticle systems in drug delivery technology. Saudi Pharm J. 2018;26:64\u201370. https:\/\/doi.org\/10.1016\/j.jsps.2017.10.012","journal-title":"Saudi Pharm J"},{"key":"1971_CR114","doi-asserted-by":"publisher","unstructured":"Wang Z, Zhang N, Lin P, Xing Y, Yang N. Recent advances in the treatment and delivery system of diabetic retinopathy. Front Endocrinol (Lausanne). 2024;15. https:\/\/doi.org\/10.3389\/fendo.2024.1347864","DOI":"10.3389\/fendo.2024.1347864"},{"key":"1971_CR115","doi-asserted-by":"publisher","unstructured":"Yang C, Yang J, Lu A, Gong J, Yang Y, Lin X, Li M, Xu H. Nanoparticles in ocular applications and their potential toxicity. Front Mol Biosci. 2022;9. https:\/\/doi.org\/10.3389\/fmolb.2022.931759","DOI":"10.3389\/fmolb.2022.931759"},{"key":"1971_CR116","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.3390\/ijms22041776","volume":"22","author":"E Pishavar","year":"2021","unstructured":"Pishavar E, Luo H, Bolander J, Atala A, Ramakrishna S, Nanocarriers P, Cells. Combinational approaches, and new insights on the retinal therapy. Int J Mol Sci. 2021;22:1776. https:\/\/doi.org\/10.3390\/ijms22041776","journal-title":"Int J Mol Sci"},{"key":"1971_CR117","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1016\/j.drudis.2022.05.024","volume":"27","author":"M Bohley","year":"2022","unstructured":"Bohley M, Dillinger AE, Tamm ER, Goepferich A. Targeted drug delivery to the retinal pigment epithelium: untapped therapeutic potential for retinal diseases. Drug Discov Today. 2022;27:2497\u2013509. https:\/\/doi.org\/10.1016\/j.drudis.2022.05.024","journal-title":"Drug Discov Today"},{"key":"1971_CR118","doi-asserted-by":"publisher","first-page":"114770","DOI":"10.1016\/j.addr.2023.114770","volume":"196","author":"H Han","year":"2023","unstructured":"Han H, Li S, Xu M, Zhong Y, Fan W, Xu J, Zhou T, Ji J, Ye J, Yao K. Polymer- and lipid-based nanocarriers for ocular drug delivery: current status and future perspectives. Adv Drug Deliv Rev. 2023;196:114770. https:\/\/doi.org\/10.1016\/j.addr.2023.114770","journal-title":"Adv Drug Deliv Rev"},{"key":"1971_CR119","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.2147\/IJN.S294807","volume":"16","author":"Y Liu","year":"2021","unstructured":"Liu Y, Wu N. Progress of nanotechnology in diabetic retinopathy treatment. Int J Nanomed Volume. 2021;16:1391\u2013403. https:\/\/doi.org\/10.2147\/IJN.S294807","journal-title":"Int J Nanomed Volume"},{"key":"1971_CR120","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3109\/08820538.2014.959198","volume":"29","author":"EK Deschler","year":"2014","unstructured":"Deschler EK, Sun JK, Silva PS. Side-Effects and complications of laser treatment in diabetic retinal disease. Semin Ophthalmol. 2014;29:290\u2013300. https:\/\/doi.org\/10.3109\/08820538.2014.959198","journal-title":"Semin Ophthalmol"},{"key":"1971_CR121","doi-asserted-by":"publisher","unstructured":"Allyn MM, Luo RH, Hellwarth EB. Swindle-Reilly, considerations for polymers used in ocular drug delivery. Front Med (Lausanne). 2022;8. https:\/\/doi.org\/10.3389\/fmed.2021.787644","DOI":"10.3389\/fmed.2021.787644"},{"key":"1971_CR122","doi-asserted-by":"publisher","first-page":"122005","DOI":"10.1016\/j.lfs.2023.122005","volume":"330","author":"Y-Y Chen","year":"2023","unstructured":"Chen Y-Y, Chen C-K, Wu T-T, Ho C-Y, Yeh T-C, Sun G-C, Tseng C-J, Cheng P-W. Attenuation of epithelial-mesenchymal transition via SGLT2 Inhibition and diabetic cataract suppression by Dapagliflozin nanoparticles treatment. Life Sci. 2023;330:122005. https:\/\/doi.org\/10.1016\/j.lfs.2023.122005","journal-title":"Life Sci"},{"key":"1971_CR123","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1021\/acs.molpharmaceut.8b01319","volume":"16","author":"F Qiu","year":"2019","unstructured":"Qiu F, Meng T, Chen Q, Zhou K, Shao Y, Matlock G, Ma X, Wu W, Du Y, Wang X, Deng G, Ma J, Xu Q. Fenofibrate-Loaded biodegradable nanoparticles for the treatment of experimental diabetic retinopathy and neovascular Age-Related macular degeneration. Mol Pharm. 2019;16:1958\u201370. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b01319","journal-title":"Mol Pharm"},{"key":"1971_CR124","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.procbio.2022.05.008","volume":"120","author":"Y Liu","year":"2022","unstructured":"Liu Y, Dong Y, Pu X, Yin X. Fabrication of anti-oxidant Curcumin loaded ceria nanoclusters for the novel delivery system to prevention of selenite-induced cataract therapy in alleviating diabetic cataract. Process Biochem. 2022;120:239\u201349. https:\/\/doi.org\/10.1016\/j.procbio.2022.05.008","journal-title":"Process Biochem"},{"key":"1971_CR125","doi-asserted-by":"publisher","first-page":"125436","DOI":"10.1016\/j.cej.2020.125436","volume":"398","author":"L Li","year":"2020","unstructured":"Li L, Li S, Wang S, Xing X, Zhang Y, Su L, Wu X, Wang H, Chang J, Gong X. Antioxidant and anti-glycated TAT-modified platinum nanoclusters as eye drops for non-invasive and painless relief of diabetic cataract in rats. Chem Eng J. 2020;398:125436. https:\/\/doi.org\/10.1016\/j.cej.2020.125436","journal-title":"Chem Eng J"},{"key":"1971_CR126","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1166\/mex.2020.1784","volume":"10","author":"C Li","year":"2020","unstructured":"Li C, Zhao G, Lu L, Du X. Effect of triamcinolone acetonide-loaded nanoparticles on diabetic retinopathy in rats. Mater Express. 2020;10:1511\u20137. https:\/\/doi.org\/10.1166\/mex.2020.1784","journal-title":"Mater Express"},{"key":"1971_CR127","doi-asserted-by":"publisher","first-page":"102286","DOI":"10.1016\/j.jddst.2020.102286","volume":"61","author":"G Rassu","year":"2021","unstructured":"Rassu G, Pavan B, Mandracchia D, Tripodo G, Botti G, Dalpiaz A, Gavini E, Giunchedi P. Polymeric nanomicelles based on inulin D \u03b1-tocopherol succinate for the treatment of diabetic retinopathy. J Drug Deliv Sci Technol. 2021;61:102286. https:\/\/doi.org\/10.1016\/j.jddst.2020.102286","journal-title":"J Drug Deliv Sci Technol"},{"key":"1971_CR128","doi-asserted-by":"publisher","first-page":"100232","DOI":"10.1016\/j.ijpx.2024.100232","volume":"7","author":"AE hakim Ramadan","year":"2024","unstructured":"hakim Ramadan AE, Elsayed MMA, Elsayed A, Fouad MA, Mohamed MS, Lee S, Mahmoud RA, Sabry SA, Ghoneim MM, Hassan AHE, Abd Elkarim RA, Belal A, El-Shenawy AA. Development and optimization of vildagliptin solid lipid nanoparticles loaded Ocuserts for controlled ocular delivery: A promising approach towards treating diabetic retinopathy. Int J Pharm X. 2024;7:100232. https:\/\/doi.org\/10.1016\/j.ijpx.2024.100232","journal-title":"Int J Pharm X"},{"key":"1971_CR129","doi-asserted-by":"publisher","first-page":"111151","DOI":"10.1016\/j.colsurfb.2020.111151","volume":"194","author":"V Dave","year":"2020","unstructured":"Dave V, Sharma R, Gupta C, Sur S. Folic acid modified gold nanoparticle for targeted delivery of Sorafenib Tosylate towards the treatment of diabetic retinopathy. Colloids Surf B Biointerfaces. 2020;194:111151. https:\/\/doi.org\/10.1016\/j.colsurfb.2020.111151","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1971_CR130","doi-asserted-by":"publisher","unstructured":"Yang R, Tang S, Xie X, Jin C, Tong Y, Huang W, Zan X. Enhanced ocular delivery of Beva via Ultra-Small polymeric micelles for noninvasive Anti\u2010VEGF therapy. Adv Mater. 2024;36. https:\/\/doi.org\/10.1002\/adma.202314126","DOI":"10.1002\/adma.202314126"},{"key":"1971_CR131","doi-asserted-by":"publisher","unstructured":"Zhao X, Seah I, Xue K, Wong W, Tan QSW, Ma X, Lin Q, Lim JYC, Liu Z, Parikh BH, Mehta KN, Lai JW, Yang B, Tran KC, Barathi VA, Cheong KH, Hunziker W, Su X, Loh XJ. Antiangiogenic nanomicelles for the topical delivery of Aflibercept to treat retinal neovascular disease. Adv Mater. 2022;34. https:\/\/doi.org\/10.1002\/adma.202108360","DOI":"10.1002\/adma.202108360"},{"key":"1971_CR132","doi-asserted-by":"publisher","first-page":"101229","DOI":"10.1016\/j.mtbio.2024.101229","volume":"28","author":"H Iqbal","year":"2024","unstructured":"Iqbal H, Razzaq A, Zhou D, Lou J, Xiao R, Lin F, Liang Y. Nanomedicine in glaucoma treatment; current challenges and future perspectives. Mater Today Bio. 2024;28:101229. https:\/\/doi.org\/10.1016\/j.mtbio.2024.101229","journal-title":"Mater Today Bio"},{"key":"1971_CR133","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejpb.2012.10.014","volume":"83","author":"H Sasaki","year":"2013","unstructured":"Sasaki H, Karasawa K, Hironaka K, Tahara K, Tozuka Y, Takeuchi H. Retinal drug delivery using Eyedrop preparations of poly-l-lysine-modified liposomes. Eur J Pharm Biopharm. 2013;83:364\u20139. https:\/\/doi.org\/10.1016\/j.ejpb.2012.10.014","journal-title":"Eur J Pharm Biopharm"},{"key":"1971_CR134","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1039\/D2NA00534D","volume":"5","author":"M Awashra","year":"2023","unstructured":"Awashra M, M\u0142ynarz P. The toxicity of nanoparticles and their interaction with cells: an in vitro metabolomic perspective. Nanoscale Adv. 2023;5:2674\u2013723. https:\/\/doi.org\/10.1039\/D2NA00534D","journal-title":"Nanoscale Adv"},{"key":"1971_CR135","doi-asserted-by":"publisher","unstructured":"H\u00fchn D, Kantner K, Geidel C, Brandholt S, De Cock I, Soenen SJH, Rivera_Gil P, Montenegro J-M, Braeckmans K, M\u00fcllen K, Nienhaus GU, Klapper M, Parak WJ. Polymer-Coated nanoparticles interacting with proteins and cells: focusing on the sign of the net charge. ACS Nano. 2013;7:3253\u201363. https:\/\/doi.org\/10.1021\/nn3059295","DOI":"10.1021\/nn3059295"},{"key":"1971_CR136","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1039\/D0MA00807A","volume":"2","author":"N Baig","year":"2021","unstructured":"Baig N, Kammakakam I, Falath W. Nanomaterials: a review of synthesis methods, properties, recent progress, and challenges. Mater Adv. 2021;2:1821\u201371. https:\/\/doi.org\/10.1039\/D0MA00807A","journal-title":"Mater Adv"},{"key":"1971_CR137","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s00604-024-06305-4","volume":"191","author":"S Bilge","year":"2024","unstructured":"Bilge S, Dogan-Topal B, G\u00fcrb\u00fcz MM, Ozkan SA, S\u0131na\u011f A. Recent trends in core\/shell nanoparticles: their enzyme-based electrochemical biosensor applications. Microchim Acta. 2024;191:240. https:\/\/doi.org\/10.1007\/s00604-024-06305-4","journal-title":"Microchim Acta"},{"key":"1971_CR138","doi-asserted-by":"publisher","first-page":"5090","DOI":"10.1039\/D0NA00411A","volume":"2","author":"V Chiozzi","year":"2020","unstructured":"Chiozzi V, Rossi F. Inorganic\u2013organic core\/shell nanoparticles: progress and applications. Nanoscale Adv. 2020;2:5090\u2013105. https:\/\/doi.org\/10.1039\/D0NA00411A","journal-title":"Nanoscale Adv"},{"key":"1971_CR139","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3390\/app8030411","volume":"8","author":"M Khatami","year":"2018","unstructured":"Khatami M, Alijani H, Nejad M, Varma R. Core@shell nanoparticles: greener synthesis using natural plant products. Appl Sci. 2018;8:411. https:\/\/doi.org\/10.3390\/app8030411","journal-title":"Appl Sci"},{"key":"1971_CR140","doi-asserted-by":"publisher","first-page":"11083","DOI":"10.1021\/acs.jpcc.4c02012","volume":"128","author":"CF Jones","year":"2024","unstructured":"Jones CF, Resina L, Ferreira FC, Sanjuan-Alberte P, Esteves T. Conductive Core\u2013Shell nanoparticles: synthesis and applications. J Phys Chem C. 2024;128:11083\u2013100. https:\/\/doi.org\/10.1021\/acs.jpcc.4c02012","journal-title":"J Phys Chem C"},{"key":"1971_CR141","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jsamd.2020.09.001","volume":"5","author":"FM Galogahi","year":"2020","unstructured":"Galogahi FM, Zhu Y, An H, Nguyen NT. Core-shell microparticles: generation approaches and applications. J Science: Adv Mater Devices. 2020;5:417\u201335. https:\/\/doi.org\/10.1016\/j.jsamd.2020.09.001","journal-title":"J Science: Adv Mater Devices"},{"key":"1971_CR142","doi-asserted-by":"publisher","first-page":"6455","DOI":"10.1021\/acsomega.7b01016","volume":"2","author":"S Deshpande","year":"2017","unstructured":"Deshpande S, Sharma S, Koul V, Singh N. Core\u2013Shell nanoparticles as an efficient, sustained, and triggered Drug-Delivery system. ACS Omega. 2017;2:6455\u201363. https:\/\/doi.org\/10.1021\/acsomega.7b01016","journal-title":"ACS Omega"},{"key":"1971_CR143","doi-asserted-by":"publisher","first-page":"122195","DOI":"10.1016\/j.ijpharm.2022.122195","volume":"627","author":"A Romeo","year":"2022","unstructured":"Romeo A, Bonaccorso A, Carbone C, Lupo G, Daniela Anfuso C, Giurdanella G, Caggia C, Randazzo C, Russo N, Romano GL, Bucolo C, Rizzo M, Tosi G, Thomas Duskey J, Ruozi B, Pignatello R, Musumeci T. Melatonin loaded hybrid nanomedicine: DoE approach, optimization and in vitro study on diabetic retinopathy model. Int J Pharm. 2022;627:122195. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122195","journal-title":"Int J Pharm"},{"key":"1971_CR144","doi-asserted-by":"publisher","first-page":"118474","DOI":"10.1016\/j.ijpharm.2019.118474","volume":"568","author":"DA Srinivasarao","year":"2019","unstructured":"Srinivasarao DA, Reddy SS, Reddy GB, Katti DS. Spatio-temporal control on the delivery of triamcinolone acetonide using polymeric nanoparticles reduces steroid induced cataract. Int J Pharm. 2019;568:118474. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118474","journal-title":"Int J Pharm"},{"key":"1971_CR145","doi-asserted-by":"publisher","first-page":"121045","DOI":"10.1016\/j.ijpharm.2021.121045","volume":"608","author":"DA Srinivasarao","year":"2021","unstructured":"Srinivasarao DA, Sreenivasa Reddy S, Bhanuprakash Reddy G, Katti DS. Simultaneous amelioration of diabetic ocular complications in lens and retinal tissues using a non-invasive drug delivery system. Int J Pharm. 2021;608:121045. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121045","journal-title":"Int J Pharm"},{"key":"1971_CR146","doi-asserted-by":"publisher","unstructured":"Yadav AS, Tran DT, Teo AJT, Dai Y, Galogahi FM, Ooi CH, Nguyen N-T. Core-Shell particles: from fabrication methods to diverse manipulation techniques. Micromachines (Basel). 2023;14. https:\/\/doi.org\/10.3390\/mi14030497","DOI":"10.3390\/mi14030497"},{"key":"1971_CR147","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.1021\/acs.biomac.0c00769","volume":"21","author":"PA Lovell","year":"2020","unstructured":"Lovell PA, Schork FJ. Fundamentals of emulsion polymerization. Biomacromolecules. 2020;21:4396\u2013441. https:\/\/doi.org\/10.1021\/acs.biomac.0c00769","journal-title":"Biomacromolecules"},{"key":"1971_CR148","doi-asserted-by":"publisher","first-page":"107750","DOI":"10.1016\/j.foodhyd.2022.107750","volume":"131","author":"B Hu","year":"2022","unstructured":"Hu B, Yang Y, Han L, Yang J, Zheng W, Cao J. Characterization of hydrophilic and hydrophobic core-shell microcapsules prepared using a range of antisolvent approaches. Food Hydrocoll. 2022;131:107750. https:\/\/doi.org\/10.1016\/j.foodhyd.2022.107750","journal-title":"Food Hydrocoll"},{"key":"1971_CR149","doi-asserted-by":"publisher","first-page":"125180","DOI":"10.1016\/j.colsurfa.2020.125180","volume":"603","author":"N Viriyakitpattana","year":"2020","unstructured":"Viriyakitpattana N, Sunintaboon P. Synthesis of crosslinked poly(methacrylic acid) shell\/lipid core colloidal nanoparticles via L-in-Lm interfacial polymerization and their pH responsiveness. Colloids Surf Physicochem Eng Asp. 2020;603:125180. https:\/\/doi.org\/10.1016\/j.colsurfa.2020.125180","journal-title":"Colloids Surf Physicochem Eng Asp"},{"key":"1971_CR150","doi-asserted-by":"publisher","unstructured":"Fan J, Liu Y, Wang S, Liu Y, Li S, Long R, Zhang R, Kankala RK. Synthesis and characterization of innovative poly(lactide-co-glycolide)-(poly-l-ornithine\/fucoidan) core\u2013shell nanocarriers by layer-by-layer self-assembly, RSC Adv 7 (2017) 32786\u201332794. https:\/\/doi.org\/10.1039\/C7RA04908K","DOI":"10.1039\/C7RA04908K"},{"key":"1971_CR151","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.xphs.2022.12.004","volume":"112","author":"F Kazemi-Andalib","year":"2023","unstructured":"Kazemi-Andalib F, Mohammadikish M, Sahebi U, Divsalar A. Layer-By-Layer synthesis of the pH-Responsive Hollow microcapsule and investigation of its drug delivery and anticancer properties. J Pharm Sci. 2023;112:1072\u201380. https:\/\/doi.org\/10.1016\/j.xphs.2022.12.004","journal-title":"J Pharm Sci"},{"key":"1971_CR152","doi-asserted-by":"publisher","first-page":"4590","DOI":"10.3390\/ma13204590","volume":"13","author":"H Chen","year":"2020","unstructured":"Chen H, Zhang L, Li M, Xie G. Synthesis of Core\u2013Shell micro\/nanoparticles and their tribological application: A review. Materials. 2020;13:4590. https:\/\/doi.org\/10.3390\/ma13204590","journal-title":"Materials"},{"key":"1971_CR153","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3390\/nano11010181","volume":"11","author":"WK Tan","year":"2021","unstructured":"Tan WK, Muto H, Kawamura G, Lockman Z, Matsuda A. Nanomaterial fabrication through the modification of Sol\u2013Gel derived coatings. Nanomaterials. 2021;11:181. https:\/\/doi.org\/10.3390\/nano11010181","journal-title":"Nanomaterials"},{"key":"1971_CR154","doi-asserted-by":"publisher","unstructured":"Wang M, Zhao Q. Electrospinning and electrospray for biomedical applications. Encyclopedia of biomedical engineering. Elsevier; 2019. pp. 330\u201344. https:\/\/doi.org\/10.1016\/B978-0-12-801238-3.11028-1","DOI":"10.1016\/B978-0-12-801238-3.11028-1"},{"key":"1971_CR155","doi-asserted-by":"publisher","first-page":"103098","DOI":"10.1016\/j.cis.2024.103098","volume":"325","author":"M Alfatama","year":"2024","unstructured":"Alfatama M, Shahzad Y, Choukaife H. Recent advances of electrospray technique for multiparticulate preparation: drug delivery applications. Adv Colloid Interface Sci. 2024;325:103098. https:\/\/doi.org\/10.1016\/j.cis.2024.103098","journal-title":"Adv Colloid Interface Sci"},{"key":"1971_CR156","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3390\/nano10030496","volume":"10","author":"M Szcz\u0119ch","year":"2020","unstructured":"Szcz\u0119ch M, Szczepanowicz K. Polymeric Core-Shell nanoparticles prepared by spontaneous emulsification solvent evaporation and functionalized by the Layer-by-Layer method. Nanomaterials. 2020;10:496. https:\/\/doi.org\/10.3390\/nano10030496","journal-title":"Nanomaterials"},{"key":"1971_CR157","doi-asserted-by":"publisher","first-page":"6165","DOI":"10.3390\/ijms23116165","volume":"23","author":"A Zieli\u0144ska","year":"2022","unstructured":"Zieli\u0144ska A, Cano A, Andreani T, Martins-Gomes C, Silva AM, Szalata M, S\u0142omski R, Souto EB. Lipid-Drug conjugates and nanoparticles for the cutaneous delivery of Cannabidiol. Int J Mol Sci. 2022;23:6165. https:\/\/doi.org\/10.3390\/ijms23116165","journal-title":"Int J Mol Sci"},{"key":"1971_CR158","doi-asserted-by":"publisher","first-page":"101824","DOI":"10.1016\/j.jscs.2024.101824","volume":"28","author":"R Wu","year":"2024","unstructured":"Wu R, Du Q, Zhang H, Zhang P, Lei X, Zhang F. A comprehensive review: the approach for fabrication of core\/shell Au nanocomposite and modification, properties, applications of Au NPs. J Saudi Chem Soc. 2024;28:101824. https:\/\/doi.org\/10.1016\/j.jscs.2024.101824","journal-title":"J Saudi Chem Soc"},{"key":"1971_CR159","doi-asserted-by":"publisher","unstructured":"Dhas NL, Raval NJ, Kudarha RR, Acharya NS, Acharya SR. Core\u2013shell nanoparticles as a drug delivery platform for tumor targeting. Inorganic frameworks as smart nanomedicines. Elsevier; 2018. pp. 387\u2013448. https:\/\/doi.org\/10.1016\/B978-0-12-813661-4.00009-2","DOI":"10.1016\/B978-0-12-813661-4.00009-2"},{"key":"1971_CR160","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1016\/j.matt.2021.05.005","volume":"4","author":"Y Lin","year":"2021","unstructured":"Lin Y, Zhou M, Tai X, Li H, Han X, Yu J. Analytical transmission electron microscopy for emerging advanced materials. Matter. 2021;4:2309\u201339. https:\/\/doi.org\/10.1016\/j.matt.2021.05.005","journal-title":"Matter"},{"key":"1971_CR161","doi-asserted-by":"publisher","unstructured":"Gutierrez RMP, Mendez JVM, Vazquez IA. A novel approach to the oral delivery of bionanostructures for systemic disease. Nanostructures for oral medicine. Elsevier; 2017. pp. 27\u201359. https:\/\/doi.org\/10.1016\/B978-0-323-47720-8.00002-X","DOI":"10.1016\/B978-0-323-47720-8.00002-X"},{"key":"1971_CR162","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s41871-022-00125-x","volume":"5","author":"R Bellotti","year":"2022","unstructured":"Bellotti R, Picotto GB, Ribotta L. Measurements and tip characterization of nanoparticles with different shapes. Nanomanuf Metrol. 2022;5:127\u201338. https:\/\/doi.org\/10.1007\/s41871-022-00125-x","journal-title":"Nanomanuf Metrol"},{"key":"1971_CR163","doi-asserted-by":"publisher","first-page":"12871","DOI":"10.1039\/C8NR02278J","volume":"10","author":"S Mourdikoudis","year":"2018","unstructured":"Mourdikoudis S, Pallares RM, Thanh NTK. Characterization techniques for nanoparticles: comparison and complementarity upon studying nanoparticle properties. Nanoscale. 2018;10:12871\u2013934. https:\/\/doi.org\/10.1039\/C8NR02278J","journal-title":"Nanoscale"},{"key":"1971_CR164","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s12551-016-0218-6","volume":"8","author":"J Stetefeld","year":"2016","unstructured":"Stetefeld J, McKenna SA, Patel TR. Dynamic light scattering: a practical guide and applications in biomedical sciences. Biophys Rev. 2016;8:409\u201327. https:\/\/doi.org\/10.1007\/s12551-016-0218-6","journal-title":"Biophys Rev"},{"key":"1971_CR165","doi-asserted-by":"publisher","unstructured":"Mohamed MA, Jaafar J, Ismail AF, Othman MHD, Rahman MA. Fourier transform infrared (FTIR) spectroscopy, in: membrane characterization. Elsevier; 2017. pp. 3\u201329. https:\/\/doi.org\/10.1016\/B978-0-444-63776-5.00001-2","DOI":"10.1016\/B978-0-444-63776-5.00001-2"},{"key":"1971_CR166","doi-asserted-by":"publisher","unstructured":"Differential Scanning Calorimetry and Thermogravimetric Analysis, in. Solid state properties of pharmaceutical materials. Wiley; 2017. pp. 124\u201341. https:\/\/doi.org\/10.1002\/9781119264408.ch10","DOI":"10.1002\/9781119264408.ch10"},{"key":"1971_CR167","doi-asserted-by":"publisher","unstructured":"Weigert F, M\u00fcller A, H\u00e4usler I, Gei\u00dfler D, Skroblin D, Krumrey M, Unger W, Radnik J, Resch-Genger U. Combining HR-TEM and XPS to elucidate the core\u2013shell structure of Ultrabright cdse\/cds semiconductor quantum Dots. Sci Rep. 2020;10. https:\/\/doi.org\/10.1038\/s41598-020-77530-z","DOI":"10.1038\/s41598-020-77530-z"},{"key":"1971_CR168","doi-asserted-by":"publisher","unstructured":"Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres M, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, Habtemariam S, Shin H-S. Nano based drug delivery systems: recent developments and future prospects, J Nanobiotechnology 16 (2018) 71. https:\/\/doi.org\/10.1186\/s12951-018-0392-8","DOI":"10.1186\/s12951-018-0392-8"},{"key":"1971_CR169","doi-asserted-by":"publisher","first-page":"5905","DOI":"10.3390\/molecules26195905","volume":"26","author":"S Adepu","year":"2021","unstructured":"Adepu S, Ramakrishna S. Controlled drug delivery systems: current status and future directions. Molecules. 2021;26:5905. https:\/\/doi.org\/10.3390\/molecules26195905","journal-title":"Molecules"},{"key":"1971_CR170","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1177\/2211068211428189","volume":"17","author":"W-W Yang","year":"2012","unstructured":"Yang W-W, Pierstorff E. Reservoir-Based Polym Drug Delivery Syst SLAS Technol. 2012;17:50\u20138. https:\/\/doi.org\/10.1177\/2211068211428189","journal-title":"Reservoir-Based Polym Drug Delivery Syst SLAS Technol"},{"key":"1971_CR171","doi-asserted-by":"publisher","first-page":"102196","DOI":"10.1016\/j.addma.2021.102196","volume":"46","author":"B Zhang","year":"2021","unstructured":"Zhang B, Gleadall A, Belton P, Mcdonagh T, Bibb R, Qi S. New insights into the effects of porosity, pore length, pore shape and pore alignment on drug release from extrusionbased additive manufactured pharmaceuticals. Addit Manuf. 2021;46:102196. https:\/\/doi.org\/10.1016\/j.addma.2021.102196","journal-title":"Addit Manuf"},{"key":"1971_CR172","doi-asserted-by":"publisher","unstructured":"Adepu S, Ramakrishna S. Controlled drug delivery systems: current status and future directions. Molecules. 2021;26. https:\/\/doi.org\/10.3390\/molecules26195905","DOI":"10.3390\/molecules26195905"},{"key":"1971_CR173","doi-asserted-by":"publisher","first-page":"487","DOI":"10.25258\/ijddt.14.1.68","volume":"14","author":"R Vishwakarma","year":"2024","unstructured":"Vishwakarma R, Tare H, Jain S. Regulating drug release with microspheres: formulation, mechanisms, and challenges. IJDDT. 2024;14:487\u201396.","journal-title":"IJDDT"},{"key":"1971_CR174","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ces.2014.08.046","volume":"125","author":"JH Lee","year":"2015","unstructured":"Lee JH, Yeo Y. Controlled drug release from pharmaceutical nanocarriers. Chem Eng Sci. 2015;125:75\u201384. https:\/\/doi.org\/10.1016\/j.ces.2014.08.046","journal-title":"Chem Eng Sci"},{"key":"1971_CR175","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1021\/ja510147n","volume":"137","author":"AP Blum","year":"2015","unstructured":"Blum AP, Kammeyer JK, Rush AM, Callmann CE, Hahn ME, Gianneschi NC. Stimuli-Responsive nanomaterials for biomedical applications. J Am Chem Soc. 2015;137:2140\u201354. https:\/\/doi.org\/10.1021\/ja510147n","journal-title":"J Am Chem Soc"},{"key":"1971_CR176","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12951-023-02017-8","volume":"21","author":"J Han","year":"2023","unstructured":"Han J, Ma Q, An Y, Wu F, Zhao Y, Wu G, Wang J. The current status of stimuli-responsive nanotechnologies on orthopedic titanium implant surfaces. J Nanobiotechnol. 2023;21:277. https:\/\/doi.org\/10.1186\/s12951-023-02017-8","journal-title":"J Nanobiotechnol"},{"key":"1971_CR177","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ijpharm.2017.11.064","volume":"544","author":"J Yu","year":"2018","unstructured":"Yu J, Zhang Y, Yan J, Kahkoska AR, Gu Z. Advances in bioresponsive closed-loop drug delivery systems. Int J Pharm. 2018;544:350\u20137. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.11.064","journal-title":"Int J Pharm"},{"key":"1971_CR178","doi-asserted-by":"publisher","first-page":"6857","DOI":"10.1021\/acsnano.3c00535","volume":"17","author":"R Ganugula","year":"2023","unstructured":"Ganugula R, Arora M, Dwivedi S, Chandrashekar DS, Varambally S, Scott EM, Kumar MNVR. Systemic Anti-Inflammatory therapy aided by Curcumin-Laden Double-Headed nanoparticles combined with injectable Long-Acting insulin in a rodent model of diabetes eye disease. ACS Nano. 2023;17:6857\u201374. https:\/\/doi.org\/10.1021\/acsnano.3c00535","journal-title":"ACS Nano"},{"key":"1971_CR179","doi-asserted-by":"publisher","unstructured":"Sanit\u00e0 G, Carrese B, Lamberti A. Nanoparticle surface functionalization: how to improve biocompatibility and cellular internalization. Front Mol Biosci. 2020;7. https:\/\/doi.org\/10.3389\/fmolb.2020.587012","DOI":"10.3389\/fmolb.2020.587012"},{"key":"1971_CR180","doi-asserted-by":"publisher","unstructured":"Ahmad F, Salem-Bekhit MM, Khan F, Alshehri S, Khan A, Ghoneim MM, Wu H-F, Taha EI, Elbagory I. Unique properties of Surface-Functionalized nanoparticles for Bio-Application: functionalization mechanisms and importance in application. Nanomaterials (Basel). 2022;12. https:\/\/doi.org\/10.3390\/nano12081333","DOI":"10.3390\/nano12081333"},{"key":"1971_CR181","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1021\/acs.molpharmaceut.6b01029","volume":"14","author":"D Huang","year":"2017","unstructured":"Huang D, Chen Y-S, Rupenthal ID. Hyaluronic acid coated albumin nanoparticles for targeted peptide delivery to the retina. Mol Pharm. 2017;14:533\u201345. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b01029","journal-title":"Mol Pharm"},{"key":"1971_CR182","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1021\/la503869d","volume":"31","author":"C Ma","year":"2015","unstructured":"Ma C, Pan P, Shan G, Bao Y, Fujita M, Maeda M. Core\u2013Shell structure, biodegradation, and drug release behavior of Poly(lactic acid)\/Poly(ethylene glycol) Block Copolymer Micelles Tuned by Macromolecular Stereostructure. Langmuir. 2015;31:1527\u201336. https:\/\/doi.org\/10.1021\/la503869d","journal-title":"Langmuir"},{"key":"1971_CR183","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2217\/nnm.12.3","volume":"7","author":"MS Muthu","year":"2012","unstructured":"Muthu MS, Wilson B. Challenges posed by the Scale-Up of nanomedicines. Nanomedicine. 2012;7:307\u20139. https:\/\/doi.org\/10.2217\/nnm.12.3","journal-title":"Nanomedicine"},{"key":"1971_CR184","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1208\/s12249-014-0177-9","volume":"15","author":"R Paliwal","year":"2014","unstructured":"Paliwal R, Babu RJ, Palakurthi S. Nanomedicine Scale-up technologies: feasibilities and challenges. AAPS PharmSciTech. 2014;15:1527\u201334. https:\/\/doi.org\/10.1208\/s12249-014-0177-9","journal-title":"AAPS PharmSciTech"},{"key":"1971_CR185","doi-asserted-by":"publisher","unstructured":"Herdiana Y, Wathoni N, Shamsuddin S, Muchtaridi M. Scale-up polymeric-based nanoparticles drug delivery systems: development and challenges, OpenNano 7 (2022) 100048. https:\/\/doi.org\/10.1016\/j.onano.2022.100048","DOI":"10.1016\/j.onano.2022.100048"},{"key":"1971_CR186","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1208\/s12248-012-9339-4","volume":"14","author":"N Desai","year":"2012","unstructured":"Desai N. Challenges in development of Nanoparticle-Based therapeutics. AAPS J. 2012;14:282\u201395. https:\/\/doi.org\/10.1208\/s12248-012-9339-4","journal-title":"AAPS J"},{"key":"1971_CR187","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.cej.2018.03.167","volume":"350","author":"L Panariello","year":"2018","unstructured":"Panariello L, Mazzei L, Gavriilidis A. Modelling the synthesis of nanoparticles in continuous microreactors: the role of diffusion and residence time distribution on nanoparticle characteristics. Chem Eng J. 2018;350:1144\u201354. https:\/\/doi.org\/10.1016\/j.cej.2018.03.167","journal-title":"Chem Eng J"},{"key":"1971_CR188","unstructured":"Ahmed H. The Challenges Behind Scaling Up Nanomaterials., AZoNano (2024)."},{"key":"1971_CR189","doi-asserted-by":"publisher","unstructured":"Baer DR. The chameleon effect: characterization challenges due to the variability of nanoparticles and their surfaces. Front Chem. 2018;6. https:\/\/doi.org\/10.3389\/fchem.2018.00145","DOI":"10.3389\/fchem.2018.00145"},{"key":"1971_CR190","doi-asserted-by":"publisher","first-page":"100048","DOI":"10.1016\/j.onano.2022.100048","volume":"7","author":"Y Herdiana","year":"2022","unstructured":"Herdiana Y, Wathoni N, Shamsuddin S, Muchtaridi M. Scale-up polymeric-based nanoparticles drug delivery systems: development and challenges. OpenNano. 2022;7:100048. https:\/\/doi.org\/10.1016\/j.onano.2022.100048","journal-title":"OpenNano"},{"key":"1971_CR191","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1039\/D0RE00188K","volume":"5","author":"O D\u0142ugosz","year":"2020","unstructured":"D\u0142ugosz O, Banach M. Inorganic nanoparticle synthesis in flow reactors \u2013 applications and future directions. React Chem Eng. 2020;5:1619\u201341. https:\/\/doi.org\/10.1039\/D0RE00188K","journal-title":"React Chem Eng"},{"key":"1971_CR192","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.addr.2018.06.024","volume":"131","author":"S M\u00fchlebach","year":"2018","unstructured":"M\u00fchlebach S. Regulatory challenges of nanomedicines and their follow-on versions: A generic or similar approach? Adv Drug Deliv Rev. 2018;131:122\u201331. https:\/\/doi.org\/10.1016\/j.addr.2018.06.024","journal-title":"Adv Drug Deliv Rev"},{"key":"1971_CR193","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.jconrel.2023.06.038","volume":"360","author":"SF Tehrani","year":"2023","unstructured":"Tehrani SF, Bharadwaj P, Leblond Chain J, Roullin VG. Purification processes of polymeric nanoparticles: how to improve their clinical translation? J Controlled Release. 2023;360:591\u2013612. https:\/\/doi.org\/10.1016\/j.jconrel.2023.06.038","journal-title":"J Controlled Release"},{"key":"1971_CR194","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1016\/0142-9612(96)00049-X","volume":"17","author":"D Lemoine","year":"1996","unstructured":"Lemoine D, Francois C, Kedzierewicz F, Preat V, Hoffman M, Maincent P. Stability study of nanoparticles of poly(\u025b-caprolactone), poly(d,l-lactide) and poly(d,l-lactide-co-glycolide). Biomaterials. 1996;17:2191\u20137. https:\/\/doi.org\/10.1016\/0142-9612(96)00049-X","journal-title":"Biomaterials"},{"key":"1971_CR195","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.drudis.2018.01.047","volume":"23","author":"V Agrahari","year":"2018","unstructured":"Agrahari V, Agrahari V. Facilitating the translation of nanomedicines to a clinical product: challenges and opportunities. Drug Discov Today. 2018;23:974\u201391. https:\/\/doi.org\/10.1016\/j.drudis.2018.01.047","journal-title":"Drug Discov Today"},{"key":"1971_CR196","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.addr.2011.02.001","volume":"63","author":"L Wu","year":"2011","unstructured":"Wu L, Zhang J, Watanabe W. Physical and chemical stability of drug nanoparticles. Adv Drug Deliv Rev. 2011;63:456\u201369. https:\/\/doi.org\/10.1016\/j.addr.2011.02.001","journal-title":"Adv Drug Deliv Rev"},{"key":"1971_CR197","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.4103\/ijo.IJO_1893_22","volume":"71","author":"CS Amrutkar","year":"2023","unstructured":"Amrutkar CS, Patil SB. Nanocarriers for ocular drug delivery: recent advances and future opportunities. Indian J Ophthalmol. 2023;71:2355\u201366. https:\/\/doi.org\/10.4103\/ijo.IJO_1893_22","journal-title":"Indian J Ophthalmol"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01971-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-01971-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01971-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T14:50:43Z","timestamp":1772549443000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-01971-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":197,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1971"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-01971-0","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,18]]},"assertion":[{"value":"8 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there is no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}